YDESW YD Bio Limited - Warrants

0.5733USD+9.22%Mkt Cap: —P/E: —6d ago

YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease trea…

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)1.24M USD

Gross Profit167.41K USD

Net Income (TTM)-8.31M USD

Revenue/Share0.02 USD

Last Price0.5733 USD

Fiscal Year End—

MR Quarter—

Employees13

CountryUS

Sector—

Industry—

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.12

EPS (TTM)—

EPS (Forward)—

52W Range

0.191368% of range0.7500

52W High0.7500 USD

52W Low0.1913 USD

Profitability

Gross Margin28.05%

Oper. Margin-382.12%

EBITDA Margin0.00%

Profit Margin-1392.61%

ROE291.05%

ROA-60.32%

Growth

Revenue Growth314.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.60M USD

CapEx (TTM)1.44M USD

FCF Margin—

FCF Yield—

Net Debt-2.66M USD

Net Debt/EBITDA0.42

Balance Sheet

Debt/Equity-0.00

Current Ratio5.23

Quick Ratio2.70

Book Value/Sh4.57 USD

Cash/Share0.04 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float16.20M

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta-0.16

S&P 52W Chg15.78%

Avg Vol (30d)10.88K

Avg Vol (10d)—

Technical Indicators

RSI (14)67.7

MACD0.0112

MACD Signal-0.0255

MACD Hist.+0.0367

BB Upper0.5798 USD

BB Middle0.4170 USD

BB Lower0.2541 USD

BB Width78.11%

ATR (14)0.0816 USD

Vol Ratio (20d)3.88x